1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary
3.1. Introduction

4. Market Overview
4.1. Introduction
4.2. Cumulative Impact of COVID-19

5. Market Dynamics
5.1. Introduction
5.2. Drivers
5.3. Restraints
5.4. Opportunities
5.5. Challenges

6. Cell Therapy Market, by Cell Type
6.1. Introduction
6.2. Differentiated Cell
6.3. Stem Cell

7. Cell Therapy Market, by Therapy Type
7.1. Introduction
7.2. Allogenic Therapies
7.3. Autologous Therapies

8. Cell Therapy Market, by Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Dermatology
8.4. Muscoskeletal Therapies
8.5. Oncology

9. Cell Therapy Market, by End-User
9.1. Introduction
9.2. Biotechnology and Pharmaceutical Companies
9.3. Hospitals and Clinics
9.4. Research Institutes

10. California Cell Therapy Market

11. Florida Cell Therapy Market

12. Illinois Cell Therapy Market

13. New York Cell Therapy Market

14. Ohio Cell Therapy Market

15. Pennsylvania Cell Therapy Market

16. Texas Cell Therapy Market

17. Competitive Landscape
17.1. FPNV Positioning Matrix
17.1.1. Quadrants
17.1.2. Business Strategy
17.1.3. Product Satisfaction
17.2. Market Ranking Analysis
17.3. Market Share Analysis, By Key Player
17.4. Competitive Scenario
17.4.1. Merger & Acquisition
17.4.2. Agreement, Collaboration, & Partnership
17.4.3. New Product Launch & Enhancement
17.4.4. Investment & Funding
17.4.5. Award, Recognition, & Expansion

18. Company Usability Profiles
18.1. Anterogen Co.,Ltd.
18.2. Astellas Pharma Inc.
18.3. Castle Creek Biosciences, Inc.
18.4. Celgene Corporation
18.5. FUJIFILM Holdings America Corporation
18.6. JCR Pharmaceuticals Co., Ltd.
18.7. Lonza Group AG
18.8. Medipost Co., Ltd.
18.9. Novartis AG
18.10. NuVasive, Inc
18.11. Pfizer Inc.
18.12. PHARMICELL Co., Ltd.
18.13. Sartorius AG
18.14. Smith & Nephew PLC
18.15. Stemedica Cell Technologies, Inc.
18.16. Takeda Pharmaceutical Company Limited
18.17. Thermo Fisher Scientific Inc.
18.18. Vericel Corporation

19. Appendix
19.1. Discussion Guide
19.2. License & Pricing

List of Figures

FIGURE 1. UNITED STATES CELL THERAPY MARKET SIZE, 2020 VS 2026 (USD MILLION)
FIGURE 2. UNITED STATES CELL THERAPY MARKET SIZE, 2018-2026 (USD MILLION)
FIGURE 3. UNITED STATES CELL THERAPY MARKET: MARKET DYNAMICS
FIGURE 4. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2020 VS 2026 (%)
FIGURE 5. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 6. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2026
FIGURE 7. UNITED STATES CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, 2018-2026 (USD MILLION)
FIGURE 8. UNITED STATES CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 9. UNITED STATES CELL THERAPY MARKET SIZE, BY STEM CELL, 2018-2026 (USD MILLION)
FIGURE 10. UNITED STATES CELL THERAPY MARKET SIZE, BY STEM CELL, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 11. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2020 VS 2026 (%)
FIGURE 12. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2020 VS 2026 (USD MILLION)
FIGURE 13. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2026
FIGURE 14. UNITED STATES CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, 2018-2026 (USD MILLION)
FIGURE 15. UNITED STATES CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 16. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, 2018-2026 (USD MILLION)
FIGURE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (%)
FIGURE 19. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2020 VS 2026 (USD MILLION)
FIGURE 20. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2026
FIGURE 21. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, 2018-2026 (USD MILLION)
FIGURE 22. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 23. UNITED STATES CELL THERAPY MARKET SIZE, BY DERMATOLOGY, 2018-2026 (USD MILLION)
FIGURE 24. UNITED STATES CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 25. UNITED STATES CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, 2018-2026 (USD MILLION)
FIGURE 26. UNITED STATES CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 27. UNITED STATES CELL THERAPY MARKET SIZE, BY ONCOLOGY, 2018-2026 (USD MILLION)
FIGURE 28. UNITED STATES CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 29. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2020 VS 2026 (%)
FIGURE 30. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2020 VS 2026 (USD MILLION)
FIGURE 31. COMPETITIVE STRATEGIC WINDOW FOR UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2026
FIGURE 32. UNITED STATES CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, 2018-2026 (USD MILLION)
FIGURE 33. UNITED STATES CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 34. UNITED STATES CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, 2018-2026 (USD MILLION)
FIGURE 35. UNITED STATES CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 36. UNITED STATES CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, 2018-2026 (USD MILLION)
FIGURE 37. UNITED STATES CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2020 VS 2026 (USD MILLION)
FIGURE 38. UNITED STATES CELL THERAPY MARKET: FPNV POSITIONING MATRIX
FIGURE 39. UNITED STATES CELL THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
FIGURE 40. COMPETITIVE SCENARIO ANALYSIS IN UNITED STATES CELL THERAPY MARKET, BY TYPE

List of Tables

TABLE 1. UNITED STATES CELL THERAPY MARKET: MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
TABLE 3. UNITED STATES CELL THERAPY MARKET SIZE, 2018-2026 (USD MILLION)
TABLE 4. UNITED STATES CELL THERAPY MARKET SIZE, BY CELL TYPE, 2018-2026 (USD MILLION)
TABLE 5. UNITED STATES CELL THERAPY MARKET SIZE, BY DIFFERENTIATED CELL, BY STATE, 2018-2026 (USD MILLION)
TABLE 6. UNITED STATES CELL THERAPY MARKET SIZE, BY STEM CELL, BY STATE, 2018-2026 (USD MILLION)
TABLE 7. UNITED STATES CELL THERAPY MARKET SIZE, BY THERAPY TYPE, 2018-2026 (USD MILLION)
TABLE 8. UNITED STATES CELL THERAPY MARKET SIZE, BY ALLOGENIC THERAPIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 9. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOLOGOUS THERAPIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 10. UNITED STATES CELL THERAPY MARKET SIZE, BY APPLICATION, 2018-2026 (USD MILLION)
TABLE 11. UNITED STATES CELL THERAPY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY STATE, 2018-2026 (USD MILLION)
TABLE 12. UNITED STATES CELL THERAPY MARKET SIZE, BY DERMATOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 13. UNITED STATES CELL THERAPY MARKET SIZE, BY MUSCOSKELETAL THERAPIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 14. UNITED STATES CELL THERAPY MARKET SIZE, BY ONCOLOGY, BY STATE, 2018-2026 (USD MILLION)
TABLE 15. UNITED STATES CELL THERAPY MARKET SIZE, BY END-USER, 2018-2026 (USD MILLION)
TABLE 16. UNITED STATES CELL THERAPY MARKET SIZE, BY BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES, BY STATE, 2018-2026 (USD MILLION)
TABLE 17. UNITED STATES CELL THERAPY MARKET SIZE, BY HOSPITALS AND CLINICS, BY STATE, 2018-2026 (USD MILLION)
TABLE 18. UNITED STATES CELL THERAPY MARKET SIZE, BY RESEARCH INSTITUTES, BY STATE, 2018-2026 (USD MILLION)
TABLE 19. UNITED STATES CELL THERAPY MARKET: SCORES
TABLE 20. UNITED STATES CELL THERAPY MARKET: BUSINESS STRATEGY
TABLE 21. UNITED STATES CELL THERAPY MARKET: PRODUCT SATISFACTION
TABLE 22. UNITED STATES CELL THERAPY MARKET: RANKING
TABLE 23. UNITED STATES CELL THERAPY MARKET: SHARE, BY KEY PLAYER, 2020
TABLE 24. UNITED STATES CELL THERAPY MARKET: MERGER & ACQUISITION
TABLE 25. UNITED STATES CELL THERAPY MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
TABLE 26. UNITED STATES CELL THERAPY MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
TABLE 27. UNITED STATES CELL THERAPY MARKET: INVESTMENT & FUNDING
TABLE 28. UNITED STATES CELL THERAPY MARKET: AWARD, RECOGNITION, & EXPANSION
TABLE 29. UNITED STATES CELL THERAPY MARKET: LICENSE & PRICING

Companies Mentioned

Anterogen Co.,Ltd.
Astellas Pharma Inc.
Castle Creek Biosciences, Inc.
Celgene Corporation
FUJIFILM Holdings America Corporation
JCR Pharmaceuticals Co., Ltd.
Lonza Group AG
Medipost Co., Ltd.
Novartis AG
NuVasive, Inc
Pfizer Inc.
PHARMICELL Co., Ltd.
Sartorius AG
Smith & Nephew PLC
Stemedica Cell Technologies, Inc.
Takeda Pharmaceutical Company Limited
Thermo Fisher Scientific Inc.
Vericel Corporation